Insights into Telehealth, Health Technology, and MedTech
Clients and candidates in our Life Sciences & Healthcare practice are seeing the recent pandemic as a turning point in Telehealth, Health Technology and MedTech. Physicians, consumers and regulators are increasingly using connected or fully-digital technologies, with some describing it as a major revolution. After 20 centuries of medicine in which doctors invariably met patients in person – the same room at the same time – the use of telemedicine is a real paradigm shift.
Telehealth and Health Technology: an overview
In recent years, technological development enabling data analytics, artificial intelligence and the healthcare Internet of Things has disrupted traditional medical operations and transformed healthcare provision into what is described as Healthcare 4.0.
The use of telemedicine is driven both by consumers, who seek to take advantage of technologies that can improve their health and quality of life, and by healthcare systems which are interested in providing quality services at reduced cost. Mobile health applications tend to target well-being and self-care (non-medical conditions), while medical devices and software dominate the market for treating medical conditions. Telemonitoring and preventative medicine are currently the predominant telemedicine interventions, along with teleconsultation.
Before the pandemic, the major area for telemedicine was primary care, with cardiovascular diseases (CVDs), chronic obstructive pulmonary diseases (COPDs) and diabetes the most common conditions targeted.
However, the use of telemedicine has skyrocketed during the Covid-19 crisis. Social distancing has become the new behavioural standard in our society, and direct personal contact is avoided where possible.
Telehealth services use smart devices for remote examination as the first point of contact with doctors; patients with mental health conditions can attend remote sessions from home.
Telemedicine triage has been made possible by AI Chatbots that make the initial diagnoses based on symptoms identified by patients. When patients show up in hospitals, they are treated in isolation rooms or wards, and hospitals use telemedicine platforms to interact, such as e-testing, e-diagnosis, e-consent and e-prescription.
Virtual visits, remote monitoring (wearable personal IoT devices used for tracking vital signs), and digital patient engagement tools are used to deliver evaluations, patient and caregiver education, physical therapy, occupational therapy, and speech therapy.
AI-powered tools are used for screening, capacity planning and monitoring.
Non-contact infrared sensor systems (such as facial thermal scans) are used to quickly single out individuals with a fever, even in crowds. Apps allow users to self-report symptoms, alerting them if they leave a “quarantine zone” in order to curb the impact of “super-spreaders”.
Capacity planning AI
Hospitals and governments rely on AI to plan for critical care shortages in ICU staff, respiratory specialists per shift, care provider-to-patient ratios and ventilator availability.
Smart field hospitals have been built, staffed largely by robots. Patient vital signs are monitored using connected thermometers and bracelet-like devices, and intelligent robots deliver medicine and food to patients.
Trends and market examples
In the midst of the crisis, several of our clients and placements in Health Technology and MedTech have seen the accelerated acceptance and usage of solutions that combine AI, Digital, Health Technology and MedTech. For example, the US MedTech AliveCor – which Pedersen & Partners supported in their internationalisation – saw a major opportunity to monitor the cardiac irregularities caused by one of the medications used to treat severe Covid-19 cases. Instead of wired machines, doctors quickly adopted the wireless Cardiac ECG device. This is a simple handheld plate that is easily disinfected and displays a clinically solid diagnosis to nurses at a distance, via an app.
Another client company, Sensium, part of The Surgical Company Group, accurately monitors and reports heart rate, respiratory rate, and axilla temperature every two minutes. Smart algorithms continuously process and analyse all patient data, generating targeted notifications of patient deterioration, efficiently bringing the nurse to the deteriorating patient. Sensium was able to add value and facilitate the work of heavily-engaged ward staff; the sensors set off an alarm which would alert nurses in the event of instant deterioration.
As well as start-ups, we are also seeing leading medical multinationals with several decades of market leadership employ agility to shift their portfolio of products and solutions towards connectivity. There is an overall trend in the industry to wrap up Medical, ICT and Digital products into innovative offerings.
New leadership qualities for telehealth executives
The acceleration in telehealth and connected medical products requires tech-savvy leadership talent with the strategy to see the next opportunities ahead. Access to hospitals is likely to remain difficult, so it is important to create relationships at more senior levels and become part of the problem-solving team. With science leaping ahead, it is important for R&D and business to bring to the table new offerings that are efficient and comprehensive with value-based outcomes.
Digital doctor-patient collaborations mean new software, new services, new technologies, new processes and new organisations. We can say the same regarding the AI and big data revolution in the Life Sciences industry.
The digital medicine paradigm shift creates new roles and the need for new leadership. Executive Search helps to define these roles and think outside the box to place successful leaders. Pedersen & Partners has an extensive track record of placing such executives, including CEO, CIO, Business Directors, International Marketing, Head of Technology Solutions and other leadership positions.
Client Partner and the Head of the Life Sciences and Healthcare Practice for Middle East & North Africa at Pedersen & Partners, based in Dubai, UAE.
Client Partner and the Country Manager for Italy at Pedersen & Partners, based in Milan.
Client Partner and the Global Head of Life Sciences & Healthcare Practice Group at Pedersen & Partners, based in Amsterdam, the Netherlands.
With input from:
Partner and the Country Manager for the Czech Republic at Pedersen & Partners, based in Prague.
Client Partner at Pedersen & Partners, based in Shanghai, China.
Client Partner and the Country Manager for Switzerland at Pedersen & Partners, based in Zurich.
Client Partner at Pedersen & Partners, based in Germany.
Client Partner and the Country Manager for Lithuania at Pedersen & Partners.
Client Partner at Pedersen & Partners, based in Munich, Germany.
Principal at Pedersen & Partners, based in Amsterdam, the Netherlands.
Consultant at Pedersen & Partners, based in New Delhi, India.
Consultant at Pedersen & Partners, based in Vienna, Austria.
Pedersen & Partners is a leading international Executive Search firm. We operate 54 wholly owned offices in 50 countries across Europe, the Middle East, Africa, Asia & the Americas. Our values Trust, Relationship and Professionalism apply to our interaction with clients as well as executives. More information about Pedersen & Partners is available at www.pedersenandpartners.com
If you would like to conduct an interview with a representative of Pedersen & Partners, or have other media-related requests, please contact: Diana Danu, Marketing and Communications Manager at: email@example.com